Skip to Content

190 77 (Capecitabine 150 mg)

Pill imprint 190 77 has been identified as Capecitabine 150 mg.

Capecitabine is used in the treatment of colorectal cancer; breast cancer, metastatic; breast cancer; pancreatic cancer; non-small cell lung cancer (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Capecitabine 150 mg 190 77
Capecitabine 150 mg 190 77
Discount Card Promo
Capecitabine
Imprint:
190 77
Strength:
150 mg
Color:
Peach
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antimetabolites
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA Inc

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide